Pmv PharmaceuticalsÂ Inc (PMVP) Financials

$1.29

$0.05 (4.03%)

As on 04-Sep-2026 16:16EDT

Market cap

$69 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.10	0.13	1.14	1.26	0.65	1.28
Gross Profit	-0.10	-0.13	-1.14	-1.26	-0.65	-1.28
Operating Expenses	79.63	86.21	84.30	78.88	77.04	58.29
Operating Profit (EBIT)	-79.66	-86.21	-85.45	-80.13	-77.04	-58.29
Other Income	--	--	--	--	3.71	0.47
Profit before Tax	-75.20	-79.91	-74.81	-68.96	-73.33	-57.82
Provision for Tax	0.02	-2.17	-16.10	0.00	-0.01	0.02
Profit after Tax (Net Income)	-75.22	-77.74	-58.71	-68.96	-73.32	-57.85
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-73.32	-57.85

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	71.50	104.71	176.08	225.69	246.03	308.56
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.44	0.84	12.43	13.45	10.79
Current Liabilities	10.57	11.42	14.37	14.03	10.83	12.22
Total Liabilities	92.64	116.56	191.29	252.15	270.31	331.57

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.66	1.34	15.63	44.74	23.30	30.28
Current Assets	81.41	115.23	175.66	207.41	247.01	301.29
Total Assets	92.64	116.56	191.29	252.15	270.31	331.57
Total Debt*	0.22	0.84	1.19	13.29	13.98	11.19
Net Current Assets	70.84	103.81	161.29	193.38	236.17	289.07

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-73.58	-51.28	-55.66	-63.76	-46.57
Cash Flow from Investing Activities	--	70.17	53.35	-50.55	-1.37	-143.58
Cash from Financing Activities	--	0.51	0.31	35.58	0.96	2.02
Net Cash Inflow / Outflow	--	--	--	--	-64.17	-188.13

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.41	-1.46	-1.14	-1.34	-1.60	-1.28
Cash EPS ($)	-1.49	-1.46	-1.12	-1.32	-1.60	-1.27
Adjusted Book Value ($)	1.34	1.97	3.41	4.39	5.38	6.81
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.38	-0.99	-1.08	-1.40	-1.03
Free Cash Flow per Share ($)	--	-1.38	-1.01	-1.10	-1.57	-1.06

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-54.98	-28.21	-27.64	-25.29	-17.04
ROE (%)	-85.37	-55.37	-29.23	-29.24	-26.44	-17.33
ROA (%)	-58.51	-50.51	-26.48	-26.40	-24.36	-16.60
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-1,974.07	-12,307.66
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	31.18	-6.82	-8.48	10.49	-32.16	-66.83
Net Profit Growth (%)	6.99	-32.42	14.87	5.94	-26.75	-67.96
EPS Growth (%)	9.55	-0.28	0.15	0.16	-0.26	-0.41
Book Value Growth (%)	-50.46	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.86	-1.33	-2.31	-5.42	-18.09
Price / Book Value	0.95	0.64	0.44	0.71	1.62	3.39
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.24	0.57	1.23	0.45	-2.22	-13.11
Close Price ($)	1.34	1.25	1.51	3.10	8.70	23.10
High Price ($)	1.88	1.84	3.46	9.72	24.27	63.22
Low Price ($)	0.96	0.81	1.40	1.18	8.13	19.73
Market Cap ($ Cr)	68.96	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.01	0.06	0.06	0.04
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.00
Current Ratio	7.70	10.09	12.22	14.78	22.80	24.66
Quick Ratio	7.70	--	--	--	--	--
Interest Coverage	--	--	--	--	-19.12	-75.02

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	13,365.95	1,567.00	905.57	1,737.75	683.74
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.